Jacqueline Hoogerbrugge
Known title: DirectorCIK: 0002075776
Associated companies
Transaction History
| OEC | ▲ Buy | Grant | 19,150 | $0 | 6/26/2026 | View on chart |
| OEC | ▲ Buy | Grant | 12,935 | $0 | 6/27/2025 | View on chart |
| OEC | ▲ Buy | Grant | 19,150 | $0 | 6/26/2026 | View on chart |
| OEC | ▲ Buy | Grant | 12,935 | $0 | 6/27/2025 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
RBC Notes Orion's Leveraged Uranium Exposure
RBC Capital Markets highlighted that Orion S.A. offers highly leveraged exposure to US uranium. This note draws attention to the company's specific positioning in the nuclear fuel sector. The stock currently trades near its average analyst target price, with a 52-week range spanning from $4.34 to $8.64.
RBC Notes Orion's Leveraged Uranium Exposure. RBC Capital Markets highlighted that Orion S.A. offers highly leveraged exposure to US uranium. This note draws attention to the company's specific positioning in the nuclear fuel sector. The stock currently trades near its average analyst target price, with a 52-week range spanning from $4.34 to $8.64.